Orthopedic surgery or orthopedics (also spelled orthopaedics) is the branch of surgery concerned with conditions involving the musculoskeletal system. Orthopedic surgeons use both surgical and non-surgical means to treat musculoskeletal trauma, sports injuries, degenerative diseases, infections, tumors, and congenital conditions.
Contrary to widespread belief, total surgical replacement of arthritic shoulder joints carries no greater risk of complications than replacement of other major joints, a Johns Hopkins study suggests.
The U.S. Food and Drug Administration (FDA) has issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs), widely-used drugs for the treatment of anemia.
Despite the fact that 8 out of 10 patients who have plastic surgery are happy with the results, nearly 40 percent wish they had done better research before the operation with regard to the potential side effects and complications.
Many orthopedic surgeons are debating whether Warsaw, Ind.-based Zimmer Holdings' knee implant Gender Solutions, which is designed specifically for women, is better for women than the standard artificial knee, Reuters reports.
For patients undergoing total knee arthroplasty, close to perfect alignment should translate into longer durability of joint replacements, according to a renowned panel of orthopaedic surgeons who discussed advancements in computer-assisted total knee replacement (TKR) surgery at the 74th Annual Meeting of the American Academy of Orthopaedic Surgeons.
Using a unique weaving machine of their design, Duke University Medical Center researchers have created a three-dimensional fabric "scaffold" that could greatly improve the ability of physicians to repair damaged joints with the patient's own stem cells.
Archus Orthopedics, Inc. has announced that the European Patent Office has confirmed the validity of its patent number EP-B-1223872 following an Opposition that concluded with oral proceedings on January 10, 2007 in Munich, Germany.
BrainLAB has signed a contract with Singapore Health Services (SingHealth), the largest healthcare group in Singapore, for the establishment of the world's first fully digital neuroscience center at Singapore General Hospital (SGH), one of Asia's leading teaching hospitals.
Even as the "population ages and more people ... need them ... geriatricians are in short supply," the New York Times reports.
The use of anti-inflammatory drugs following hip replacement surgery could do more harm than good, according to a new study co-coordinated by The George Institute for International Health in association with orthopedic centres throughout Australian and New Zealand.
Archus Orthopedics has announced that it has been awarded its seventh United States Patent.
Nurses offer care and comfort, but they often end up with a pain in the back for their efforts, the results of a new study show.
The proliferation of heart institutes, cancer centers, orthopedic hospitals and other niche specialty centers signals an escalation in a new medical arms race as hospitals and physicians develop and market profitable specialty-service lines.
Many conservative methods used to treat work-related complaints of the upper body have only limited effectiveness, according to an updated systematic review by Arianne Verhagen, Ph.D., and her colleagues in the Netherlands.
A baby boy in China has been born with an unusually well-formed third arm and doctors are considering surgical options for him.
People whose recurrent headaches have been diagnosed as tension-related actually may be suffering from temporomandibular muscle and joint disorder, or TMJD, a study headed by a researcher from the University at Buffalo's School of Dental Medicine has shown.
There is a new option for patients suffering from hip pain who do not want to give up their active lifestyle.
Ross Wilkins and Stephen Withrow are doctors working together in the fight against bone cancer. Their goals are the same. Their patients are not.
The clinical trial for Duchenne muscular dystrophy (DMD) tests the safety and effectiveness of a therapy that was developed over two decades by scientists at the University of North Carolina Chapel Hill's School of Medicine and the University of Pittsburgh.
A novel growth factor significantly improves the ability of specialized stem cells derived from human fat to be transformed into cartilage cells, according to Duke University Medical Center and Pratt School of Engineering researchers.